Background: Cardiovascular diseases (CVD) represent a heavy economic burden on
individuals, health services, and society. Low adherence to antihypertensive (AH) agents is …

Background and Purpose— The benefits of antihypertensive (AH) drugs on the risks of
major cardiovascular outcomes have been demonstrated in clinical trials. However, …

Purpose The purpose of this study was to evaluate the ability of poly(ethylene glycol)-coated
lipid nanocapsules (LN) to deliver the highly potent hydrophobic anticancer drug docetaxel …

Background Standard survival statistics do not take into consideration the changes in the
weight of individual variables at subsequent times after the diagnosis and initial treatment of …

PURPOSE: To compare the incidence of intraoperative floppy-iris syndrome (IFIS) in men
exposed to tamsulosin and men exposed to alfuzosin and evaluate the effect of IFIS on the …

Background Statins reduce cardiovascular morbidity and mortality after continuous treatment.
Studies have shown that less than 50% of patients take 80% or more of prescribed doses 1 …

WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • Non‐adherence is probably an
important source of preventable cardiovascular morbidity and mortality. • However, until now …

What is already known about this subject • There is a major gap between the use of statins
in clinical trial settings and in actual practice. • Unfortunately, little is known about the impact …

Background Antihypertensive agents have been found to decrease morbidity and/or mortality
associated with cardiovascular disease (CVD). Surveys have shown that hypertension has …

Objective: Statins have been shown to reduce the risk of major cardiovascular disease. We
recognize that there is a major gap between the use of statins in actual practice and …